Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

673 ! Thu, 8/2/2018, 10:30 AM - 12:20 PM CC-West 120
Clinical Trial Design- 8 — Contributed Papers
Biopharmaceutical Section
Chair(s): John Pesko
10:35 AM A Simulation Study Comparing MCP-Mod and a Model-Based Approach in Phase 2a Clinical Trials

Hongtao Zhang; Alan Hartford, AbbVie Inc
10:50 AM On Sample Size Requirement for Analytical Similarity Assessment

Victoria Chang, AbbVie; Yi Zhao, Statistics Collaborative; Shein-Chung Chow, Food and Drug Administration
11:05 AM Bayesian Predictive Probability for Interim Analysis

Dung-Tsa Chen, Moffitt Cancer Center
11:20 AM Periodic Benefit-Risk Assessment Using Bayesian Stochastic Multi-Criteria Acceptability Analysis
Sammy Yuan, Merck; Kan Li, University of Texas Health Science Center; Bill Wang, Merck
11:35 AM On Evaluation of Consistency in Multi-Regional Clinical Trials
Lisa Ying; Fuyu Song, Center for Food and Drug Inspection, cFDA; Shein-Chung Chow, Food and Drug Administration; Na Zeng, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital; Jiayin Zheng, Fred Hutchinson Cancer Research Center; Xiaodong Li, Bristol-Myers Squibb Company; David Henry, Bristol-Myers Squibb Company; Venkat Sethuraman, ZS Associates
11:50 AM Selecting Among Treatments with Two Bernoulli Endpoints

Elena M Buzaianu, University of North Florida; Pinyuen Chen, Syracuse University; Lifang Hsu, Le Moyne College
12:05 PM Floor Discussion